Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Ahmad JaliliStephan N Wagner

Abstract

Cutaneous squamous cell carcinoma (SCC) is one of the most common cancers worldwide. Epidermal growth factor receptor (EGFR) is expressed at the cell surface by more than 90% of SCCs and its activation is responsible for cell cycle progression, proliferation, survival, angiogenesis and metastasis. Cyclooxygenase-2 (COX-2) is an enzyme up-regulated through EGFR signaling and responsible for some of the EGFR-dependent biological effects. An 88-year-old man presented with a recurrent, locoregionally meta-static SCC of the right parietal region, which was resistant to radiotherapy. With a combination therapy of an EGFR blocker (cetuximab) and a COX-2 inhibitor (celecoxib), the tumor regressed partially and the patient's Karnofsky index improved. We speculate that the combined use of cetuximab and COX-2 inhibitors can be a new and effective therapy for advanced and recurrent cutaneous SCCs.

References

Mar 29, 2001·The New England Journal of Medicine·M Alam, D Ratner
Jul 28, 2001·The New England Journal of Medicine·A H Rook, M Shapiro
Jun 26, 2003·The Journal of Biological Chemistry·F Gregory BuchananRaymond N DuBois
Sep 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Scott M LippmanAndrew J Dannenberg
Oct 4, 2005·The Lancet Oncology·Margot A Gosney
Feb 10, 2006·The New England Journal of Medicine·James A BonnerK Kian Ang
Dec 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mayumi Ono, Michihiko Kuwano
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eunice L KwakBruce Chabner

❮ Previous
Next ❯

Citations

May 28, 2011·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Misbah H KhanSimon Yoo
Feb 11, 2010·Molecular Cancer Research : MCR·Hui-Wen LoFrancis Ali-Osman
Jun 8, 2010·Head & Face Medicine·Michael SandFalk G Bechara
May 11, 2011·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·M SchlaakC Mauch
Apr 24, 2012·Expert Opinion on Biological Therapy·Uwe Wollina
Aug 13, 2011·Clinical Oncology : a Journal of the Royal College of Radiologists·D GiaccheroF Peyrade
May 5, 2011·Seminars in Cutaneous Medicine and Surgery·Nicole R LeBoeuf, Chrysalyne D Schmults
Jan 5, 2013·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Ioannis Manousaridis, Martin Leverkus
Feb 22, 2013·The Australasian Journal of Dermatology·Daniel C GaffneyFiona Simpson
Oct 18, 2016·The British Journal of Dermatology·J K WinklerJ C Hassel
Apr 7, 2017·Dermatology : International Journal for Clinical and Investigative Dermatology·Olivier DereureBernard Guillot
Jun 17, 2011·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·M B KarpovaR Dummer
Feb 8, 2011·American Journal of Clinical Oncology·James Leroy Wells, Keisuke Shirai
Apr 24, 2010·Journal of Medical Primatology·Elizabeth M StringerMichael R Loomis
Sep 13, 2016·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Cameron TrodelloAshley Wysong
Jul 21, 2011·Experimental Dermatology·Andreas MauererChristian Hafner
Apr 26, 2020·International Journal of Molecular Sciences·Roberto Corchado-CobosJavier Cañueto
Aug 28, 2020·Cold Spring Harbor Molecular Case Studies·Ashley N AndersonMolly Kulesz-Martin
Feb 18, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Xiao-Yan MuGao Li
Jun 25, 2018·Cancer Metastasis Reviews·Cheng-Chieh Yang, Kuo-Wei Chang
Jan 21, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carol M LewisRandal S Weber
Jul 23, 2021·American Journal of Clinical Dermatology·Ping-Chen HouChao-Kai Hsu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.